Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Acquisitions (2025)

Maxcyte (MXCT) has disclosed Acquisitions for 1 consecutive years, with $1.8 million as the latest value for Q1 2025.

  • Quarterly Acquisitions changed N/A to $1.8 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, changed N/A year-over-year, with the annual reading at $1.8 million for FY2025, N/A changed from the prior year.
  • Acquisitions for Q1 2025 was $1.8 million at Maxcyte.
  • The five-year high for Acquisitions was $1.8 million in Q1 2025, with the low at $1.8 million in Q1 2025.